Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-09 TOBIN JAMES R Director Sale −9,968 $32.80 $327K 424,837
2021-02-09 TOBIN JAMES R Director Sale −200 $34.18 $7K 424,637
2021-02-09 ABRAMS CAPITAL MANAGEMENT, L.P. 10% owner Sale −786,664 $33.32 $26.2M 2,624,712
2021-02-08 Gordon Stephen Chief Financial Officer Sale −8,571 $25.01 $214K 0
2021-02-08 Gordon Stephen Chief Financial Officer Exercise or conversion +1,429 $0.67 $957 1,429
2021-02-08 Gordon Stephen Chief Financial Officer Sale −1,429 $25.01 $36K 0
2021-02-08 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −1,429 55,713
2021-02-08 ABRAMS CAPITAL MANAGEMENT, L.P. 10% owner Sale −88,483 $26.24 $2.3M 3,411,376
2021-01-19 Sullivan John F VP of Quality & Engineering Exercise or conversion +9,617 $0.39 $4K 20,445
2021-01-19 Sullivan John F VP of Quality & Engineering Sale −9,617 $22.12 $213K 10,828
2021-01-19 Sullivan John F VP of Quality & Engineering Exercise or conversion · Stock Option (Right to Buy) −9,617 1,000
2021-01-05 Hassanein Waleed H President & CEO Exercise or conversion +123,414 $0.39 $48K 338,843
2021-01-05 Hassanein Waleed H President & CEO Exercise or conversion · Stock Option (Right to Buy) −123,414 0
2021-01-04 Gordon Stephen Chief Financial Officer Sale −1,184 $20.00 $24K 8,371
2021-01-01 RAINES MERILEE Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2020-12-31 Gordon Stephen Chief Financial Officer Sale −8,816 $20.00 $176K 9,755
2020-12-21 Sullivan John F VP of Quality & Engineering Sale −1,000 $17.99 $18K 10,828
2020-12-16 Sullivan John F VP of Quality & Engineering Exercise or conversion +1,000 $0.39 $390 11,828
2020-12-16 Sullivan John F VP of Quality & Engineering Exercise or conversion · Stock Option (Right to Buy) +1,000 10,617
2020-12-15 Sullivan John F VP of Quality & Engineering Exercise or conversion +3,000 $0.39 $1K 13,828

Page 47 of 49 · 980 trades